BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21907176)

  • 1. Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.
    van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
    Am J Pathol; 2011 Nov; 179(5):2559-68. PubMed ID: 21907176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis.
    van den Hoogen C; van der Horst G; Cheung H; Buijs JT; Pelger RC; van der Pluijm G
    Clin Exp Metastasis; 2011 Oct; 28(7):615-25. PubMed ID: 21647815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.
    van der Horst G; van den Hoogen C; Buijs JT; Cheung H; Bloys H; Pelger RC; Lorenzon G; Heckmann B; Feyen J; Pujuguet P; Blanque R; Clément-Lacroix P; van der Pluijm G
    Neoplasia; 2011 Jun; 13(6):516-25. PubMed ID: 21677875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of alpha-v integrins reduces malignancy of bladder carcinoma.
    van der Horst G; Bos L; van der Mark M; Cheung H; Heckmann B; Clément-Lacroix P; Lorenzon G; Pelger RC; Bevers RF; van der Pluijm G
    PLoS One; 2014; 9(9):e108464. PubMed ID: 25247809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
    Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression.
    Zoni E; van der Horst G; van de Merbel AF; Chen L; Rane JK; Pelger RC; Collins AT; Visakorpi T; Snaar-Jagalska BE; Maitland NJ; van der Pluijm G
    Cancer Res; 2015 Jun; 75(11):2326-36. PubMed ID: 25858144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
    Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
    Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between αv-Integrin and HER2 and Their Role in the Invasive Phenotype of Breast Cancer Cells In Vitro and in Rat Brain.
    Lal S; Kersch C; Beeson KA; Wu YJ; Muldoon LL; Neuwelt EA
    PLoS One; 2015; 10(7):e0131842. PubMed ID: 26222911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.
    Kroon J; in 't Veld LS; Buijs JT; Cheung H; van der Horst G; van der Pluijm G
    Oncotarget; 2014 Oct; 5(19):8986-94. PubMed ID: 25344861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
    Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
    Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of c-MET induces a stem-like phenotype in human prostate cancer.
    van Leenders GJ; Sookhlall R; Teubel WJ; de Ridder CM; Reneman S; Sacchetti A; Vissers KJ; van Weerden W; Jenster G
    PLoS One; 2011; 6(11):e26753. PubMed ID: 22110593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
    Hurt EM; Kawasaki BT; Klarmann GJ; Thomas SB; Farrar WL
    Br J Cancer; 2008 Feb; 98(4):756-65. PubMed ID: 18268494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells.
    Chen X; Corbin JM; Tipton GJ; Yang LV; Asch AS; Ruiz-Echevarría MJ
    Biochim Biophys Acta; 2014 Jun; 1843(6):1216-24. PubMed ID: 24632071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin induces stem cell-like phenotype in prostate cancer cells.
    Aldahish A; Kale A; Aljameeli A; Shah GV
    Endocr Relat Cancer; 2019 Nov; 26(11):815-828. PubMed ID: 31561211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancer.
    Wang N; Docherty F; Brown HK; Reeves K; Fowles A; Lawson M; Ottewell PD; Holen I; Croucher PI; Eaton CL
    FASEB J; 2015 Aug; 29(8):3141-50. PubMed ID: 25888599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin promotes in vivo metastasis of prostate cancer cells by altering cell signaling, adhesion, and inflammatory pathways.
    Shah GV; Thomas S; Muralidharan A; Liu Y; Hermonat PL; Williams J; Chaudhary J
    Endocr Relat Cancer; 2008 Dec; 15(4):953-64. PubMed ID: 18784182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo.
    Trikha M; Zhou Z; Nemeth JA; Chen Q; Sharp C; Emmell E; Giles-Komar J; Nakada MT
    Int J Cancer; 2004 Jun; 110(3):326-35. PubMed ID: 15095296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
    Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
    J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into homeobox B9: a propeller for metastasis in dormant prostate cancer progenitor cells.
    Sui Y; Hu W; Zhang W; Li D; Zhu H; You Q; Zhu R; Yi Q; Tang T; Gao L; Zhu S; Yang T
    Br J Cancer; 2021 Sep; 125(7):1003-1015. PubMed ID: 34247196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.